Annotation Detail for SF3B2

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa03040 | Spliceosome |
| Pathway ID | Pathway Name |
|---|
| mRNA Processing |
| Gene Expression |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SF3B2 mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SF3B2 mRNA | affects expression | 21346803
|
| C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of SF3B2 mRNA | decreases expression | 17616710
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of SF3B2 mRNA | affects expression | 19015723
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.97 | 19015723 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.10 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.10 | 16705839 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.03 | 6135515 |
| MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.75 | 20423518 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.85 | 14966744 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.83 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.83 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.16 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.16 | 21346803 18551238 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.57 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
6.02 | 16417039 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.29 | 16467254 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.53 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.53 | 16705839 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.36 | 16417039 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.27 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.77 | 6135515 2876786 2876784 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
12.54 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
12.54 | 18551238 7678174 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.23 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
10.23 | 16049721 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.53 | 18220299 19015723 18042343 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.57 | 18220299 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.57 | 18629315 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.74 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.74 | 18551238 |
| MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
5.57 | 15864552 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.43 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.43 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
14.19 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
14.19 | 10091137 |